Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluating the Performance of Large Language Models on a Neurology Board-Style Examination

Marc Cicero Schubert, Wolfgang Wick, View ORCID ProfileVarun Venkataramani
doi: https://doi.org/10.1101/2023.07.13.23292598
Marc Cicero Schubert
1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany
2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Wick
1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany
2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Varun Venkataramani
1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany
2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Varun Venkataramani
  • For correspondence: varun.venkataramani{at}med.uni-heidelberg.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Summary

Background and Objectives Recent advancements in large language models (LLMs) such as GPT-3.5 and GPT-4 have shown impressive potential in a wide array of applications, including healthcare. While GPT-3.5 and GPT-4 showed heterogeneous results across specialized medical board examinations, the performance of these models in neurology board exams remains unexplored.

Methods An exploratory, prospective study was conducted between May 17 and May 31, 2023. The evaluation utilized a question bank approved by the American Board of Psychiatry and Neurology, designed as part of a self-assessment program. Questions were presented in a single best answer, multiple-choice format. The results from the question bank were validated with a small question cohort by the European Board for Neurology. All questions were categorized into lower-order (recall, understanding) and higher-order (apply, analyze, synthesize) questions. The performance of GPT-3.5 and GPT-4 was assessed in relation to overall performance, question type, and topic. In addition, the confidence level in responses and the reproducibility of correctly and incorrectly answered questions was evaluated. Univariable analysis was carried out. Chi-squared test and Bonferroni correction were used to determine performance differences based on question characteristics. To differentiate characteristics of correctly and incorrectly answered questions, a high-dimensional tSNE analysis of the question representations was performed.

Results In May 2023, GPT-3.5 correctly answered 66.8 % of 1956 questions, whereas GPT-4 demonstrated a higher performance level, correctly answering 85 % of questions in congruence with near-passing and passing of the neurology board exam. GPT-4’s performance surpassed both GPT-3.5 and question bank users (mean human user score: 73.8%). An analysis of twenty-six question categories showed that GPT-4 outperformed human users in Behavioral, Cognitive and Psych-related questions and demonstrated superior performance to GPT-3.5 in six categories. Both models performed better on lower-order than higher-order questions according to Bloom Taxonomy for learning and assessment (GPT4: 790 of 893 (88.5%) vs. 872 of 1063 (82%), GPT-3.5: 639 of 893 (71.6%) vs. 667 of 1063 (62.7%)) with GPT-4 also excelling in both lower-order and higher-order questions. The use of confident language was observed consistently across both models, even when incorrect (GPT-4: 99.3%, 292 of 294 incorrect answers, GPT-3.5: 100%, 650 of 650 incorrect answers). Reproducible answers of GPT-3.5 and GPT-4 (defined as more than 75 % same output across 50 independent queries) were associated with a higher percentage of correct answers (GPT-3.5: 66 of 88 (75%), GPT-4: 78 of 96 (81.3%)) than inconsistent answers, (GPT-3.5: 5 of 13 (38.5%), GPT-4: 1 of 4 (25%)). Lastly, the high-dimensional embedding analysis of correctly and incorrectly answered questions revealed no clear differentiation into distinct clusters.

Discussion Despite the absence of neurology-specific training, GPT-4 demonstrated commendable performance, whereas GPT-3.5 performed slightly below the human average question bank user. Higher-order cognitive tasks proved more challenging for both GPT-4 and GPT-3.5. Notwithstanding, GPT-4’s performance was equivalent to a passing grade for specialized neurology board exams. These findings suggest that with further refinements, LLMs like GPT-4 could play a pivotal role in applications for clinical neurology and healthcare in general.

Competing Interest Statement

W.W. is inventor of the patent WO2017020982A1 Agents for use in the treatment of glioma. This patent covers new treatment strategies that all target the formation and function of TMs in glioma.

Funding Statement

None.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted July 14, 2023.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluating the Performance of Large Language Models on a Neurology Board-Style Examination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluating the Performance of Large Language Models on a Neurology Board-Style Examination
Marc Cicero Schubert, Wolfgang Wick, Varun Venkataramani
medRxiv 2023.07.13.23292598; doi: https://doi.org/10.1101/2023.07.13.23292598
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evaluating the Performance of Large Language Models on a Neurology Board-Style Examination
Marc Cicero Schubert, Wolfgang Wick, Varun Venkataramani
medRxiv 2023.07.13.23292598; doi: https://doi.org/10.1101/2023.07.13.23292598

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3292)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13374)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)